Viatris Gross Profit 2010-2024 | VTRS

Viatris annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Viatris gross profit for the quarter ending September 30, 2024 was $1.459B, a 13.72% decline year-over-year.
  • Viatris gross profit for the twelve months ending September 30, 2024 was $6.005B, a 1.82% decline year-over-year.
  • Viatris annual gross profit for 2023 was $6.439B, a 0.9% decline from 2022.
  • Viatris annual gross profit for 2022 was $6.497B, a 16.53% increase from 2021.
  • Viatris annual gross profit for 2021 was $5.576B, a 46.85% increase from 2020.
Viatris Annual Gross Profit
(Millions of US $)
2023 $6,439
2022 $6,497
2021 $5,576
2020 $3,797
2019 $3,898
2018 $4,002
2017 $4,783
2016 $4,697
2015 $4,216
2014 $3,528
2013 $3,040
2012 $2,908
2011 $2,563
2010 $2,217
2009 $2,074
Viatris Quarterly Gross Profit
(Millions of US $)
2024-09-30 $1,459
2024-06-30 $1,445
2024-03-31 $1,504
2023-12-31 $1,597
2023-09-30 $1,691
2023-06-30 $1,609
2023-03-31 $1,542
2022-12-31 $1,274
2022-09-30 $1,748
2022-06-30 $1,703
2022-03-31 $1,771
2021-12-31 $1,546
2021-09-30 $1,574
2021-06-30 $1,328
2021-03-31 $1,127
2020-12-31 $706
2020-09-30 $1,159
2020-06-30 $1,026
2020-03-31 $906
2019-12-31 $1,087
2019-09-30 $1,072
2019-06-30 $933
2019-03-31 $805
2018-12-31 $1,016
2018-09-30 $1,039
2018-06-30 $963
2018-03-31 $984
2017-12-31 $1,295
2017-09-30 $1,178
2017-06-30 $1,225
2017-03-31 $1,085
2016-12-31 $1,335
2016-09-30 $1,283
2016-06-30 $1,172
2016-03-31 $907
2015-12-31 $1,063
2015-09-30 $1,315
2015-06-30 $1,008
2015-03-31 $830
2014-12-31 $969
2014-09-30 $1,012
2014-06-30 $809
2014-03-31 $738
2013-12-31 $796
2013-09-30 $809
2013-06-30 $742
2013-03-31 $694
2012-12-31 $742
2012-09-30 $793
2012-06-30 $703
2012-03-31 $670
2011-12-31 $645
2011-09-30 $658
2011-06-30 $669
2011-03-31 $591
2010-12-31 $579
2010-09-30 $580
2010-06-30 $542
2010-03-31 $516
2009-12-31 $516
2009-09-30 $505
2009-06-30 $528
2009-03-31 $526
Sector Industry Market Cap Revenue
Medical Medical Services $15.576B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00